LS

Latha Subramanian

Active Director Director DIN 03129672
DIN 03129672 First appointment Jun 2010 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 4 historical roles
Total affiliations 8 Since Jun 2010
Shareholding value •••• Premium profile

About Latha Subramanian

Data last updated:

Latha Subramanian is a Director at Grandix Speciality Formulations Private Limited (since 2019), Director at Grandix Global Pharma Private Limited (since 2024) and Director at Grandix Olympus Fertility Formulations Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Trading and Pharma. The largest current company by reported revenue is Grandix Speciality Formulations Private Limited at ₹5.5 Lakh (FY 2020). Earlier, Latha Subramanian was a Managing Director at Olympus Therapeutics Private Limited (2018–2025) and Director at Zenox Lifesciences Limited (2010–2011) and 2 more.

DIN 03129672
Primary Designation Director
Industry Trading
First Appointment 23 Jun 2010
Oldest Company Age 14 yrs
Largest company Grandix Speciality Formulations Private Limited · ₹5.5 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jun 20192017₹5.5 Lakh (FY 2020)Active
Director01 Apr 20242017Active
Director24 Oct 20252025Active
Director03 Sep 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Olympus Therapeutics Private Limited U24290TN2015PTC101114
Managing Director22 Oct 20182015₹16.90 Cr (FY 2025)Active
Zenox Lifesciences Limited U51109TN2010PLC076261
Director23 Jun 20102010Under Liquidation
Director17 Sep 20122012Strike Off
Director09 Jul 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Grandix Speciality Formulations Private Limited
Syntellect Healthcare Solutions Private Limited
Otc Wellness Products Private Limited
Js Labs Fertility Formulations Private Limited
Premium access

Shareholding and investment profile for Latha Subramanian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Latha Subramanian

Latha Subramanian currently holds 4 directorships: Grandix Speciality Formulations Private Limited (Director, since 26 Jun 2019, revenue ₹5.5 Lakh (FY 2020)); Grandix Global Pharma Private Limited (Director, since 01 Apr 2024); Grandix Olympus Fertility Formulations Private Limited (Director, since 24 Oct 2025); Js Labs Fertility Formulations Private Limited (Director, since 03 Sep 2025).

Latha Subramanian was first appointed on 23 Jun 2010 as Director at Zenox Lifesciences Limited. The most recent appointment on record is 24 Oct 2025 at Grandix Olympus Fertility Formulations Private Limited.

Latha Subramanian held 4 earlier board appointments: Olympus Therapeutics Private Limited (Managing Director, 22 Oct 2018 to 20 Mar 2025); Zenox Lifesciences Limited (Director, 23 Jun 2010 to 30 Jun 2011); Syntellect Healthcare Solutions Private Limited (Director, from 17 Sep 2012); Otc Wellness Products Private Limited (Director, from 09 Jul 2012).

The current boards of Latha Subramanian's companies include Thangavelu Subramanian (Grandix Speciality Formulations Private Limited), Karnnanidhi Venneela Ramanar (Grandix Global Pharma Private Limited), Adith S M (Grandix Olympus Fertility Formulations Private Limited), Akshay S M (Grandix Olympus Fertility Formulations Private Limited), Sekaripuram Anantaraman Manikandan (Grandix Olympus Fertility Formulations Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available